Postanitbiotic and sub-MIC effects of azithromycin and isepamicin against Staphylococcus aureus and Escherichia coli.

Antimicrobial Agents and Chemotherapy
F FuentesJ Prieto

Abstract

Investigations of pharmacodynamic parameters (postantibiotic effect [PAE], sub-MIC effects [SMEs], etc.) have been progressively employed for the design of dosing schedules of antimicrobial agents. However, there are fewer in vivo than in vitro data, probably because of the simplicity of the in vitro procedures. In this study, we have investigated the in vitro PAE, SME, and previously treated (postantibiotic [PA]) SME (1/2 MIC, 1/4 MIC and 1/8 MIC) of azithromycin and isepamicin against standard strains of Staphylococcus aureus and Escherichia coli by using centrifugation to remove the antibiotics. In addition, the in vivo PAE and SME have been studied with the thigh infection model in neutropenic mice. Finally, in vivo killing curves with two dosing schedules were determined to examine whether the PAE can cover the time that antimicrobial agents are below the MIC. The two antimicrobial agents induced moderate-to-high in vitro PAEs, SMEs, and PA SMEs against S. aureus (>8 h) and E. coli (3.38 to >7.64 h). The in vivo PAEs were also high (from 3.0 to 3.6 h), despite the fact that isepamicin had lower times above the MIC in serum. Only azithromycin showed a high in vivo SME against the two strains (1.22 and 1.75 h), which indicat...Continue Reading

References

Feb 1, 1977·The Journal of Infectious Diseases·P J McDonaldC M Kunin
Sep 1, 1992·Antimicrobial Agents and Chemotherapy·I Odenholt-TornqvistO Cars
Oct 1, 1991·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·P J McDonald, H Pruul
Sep 1, 1991·Antimicrobial Agents and Chemotherapy·I Odenholt-TornqvistO Cars
Jan 1, 1990·The Journal of Antimicrobial Chemotherapy·G FouldsR B Johnson
Oct 1, 1989·Antimicrobial Agents and Chemotherapy·J Renneberg, M Walder
Aug 1, 1989·The Journal of Antimicrobial Chemotherapy·I OdenholtO Cars
Feb 1, 1988·The Journal of Infectious Diseases·B VogelmanW A Craig
Dec 1, 1986·The Journal of Antimicrobial Chemotherapy·S GudmundssonW A Craig
Dec 1, 1993·The Journal of Antimicrobial Chemotherapy·M M Martín CamineroJ Prieto Prieto
May 1, 1993·The Journal of Antimicrobial Chemotherapy·O Cars, I Odenholt-Tornqvist
May 1, 1993·The Journal of Antimicrobial Chemotherapy·S GudmundssonW A Craig
Jun 1, 1993·The Journal of Antimicrobial Chemotherapy·I Odenholt-Tornqvist
Jan 1, 1995·Scandinavian Journal of Infectious Diseases·F FuentesJ Prieto

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.